By Tim Ryan
In a remarkable recognition of its innovative prowess, ivWatch, a Hampton Roads-based medical technology firm, has been featured in PM360’s prestigious annual Innovations Issue. This honor, bestowed by one of the leading magazines in the life sciences and healthcare marketing sectors, underscores ivWatch’s significant contribution to advancing medical technology.
PM360 has highlighted ivWatch’s patented Patient Monitor and SmartTouch Sensor in the Health Technology, Non-Consumer category. This inclusion not only celebrates ivWatch’s cutting-edge technology but also aligns the company with some of the most groundbreaking advancements in life sciences, healthcare, and marketing.
ivWatch, recognized for its sole FDA-cleared and CE Marked continuous IV site monitoring technology, boasts a robust portfolio of 71 patents worldwide. These patents protect its core technologies and underscore the company’s relentless commitment to innovation. The medical device technology, notably the ivWatch Monitoring System and the SmartTouch Sensor, is designed to notify clinicians in real time of IV infiltrations or extravasations, detecting fluid leakage outside of the vein into surrounding tissue at the earliest stages. This capability is crucial in reducing patient harm and improving outcomes in IV therapy.
To read the rest of the article, visit Hampton Roads’ ivWatch Revolutionizes Healthcare with new IV Sensor and Celebrated for Innovation – Innovate Hampton Roads (innovate757.org)